OnKure Therapeutics, Inc. (OKUR)
OnKure Therapeutics, Inc. (OKUR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.
As of Oct 23, 2026: market cap $97.6M; returns 1 day -2.3%, 1 week +20.0%, 1 year -15.4%.
OnKure Therapeutics, Inc. (NASDAQ: OKUR) is a clinical-stage biopharmaceutical company headquartered in Boulder, Colorado, focused on the discovery and development of precision medicines for cancer.
Groups OKUR belongs to
- Clinical Stage Biotech
- Biotechnology
- Oncology
- Healthcare
- Precision Medicine
- Pharmaceuticals
- Drug Discovery
- Life Sciences
- Cancer Therapeutics
- Clinical Stage
- Clinical Stage Biopharma
- Breast Cancer Treatment
OKUR financial model: income statement, cash flow and balance sheet